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Abstract
RNase Z is an endonuclease responsible for the removal of 39 extensions from tRNA precursors, an essential step in tRNA
biogenesis. Human cells contain a long form (RNase Z
L) encoded by ELAC2, and a short form (RNase Z
S; ELAC1). We studied
their subcellular localization by expression of proteins fused to green fluorescent protein. RNase Z
S was found in the cytosol,
whereas RNase Z
L localized to the nucleus and mitochondria. We show that alternative translation initiation is responsible
for the dual targeting of RNase Z
L. Due to the unfavorable context of the first AUG of ELAC2, translation apparently also
starts from the second AUG, whereby the mitochondrial targeting sequence is lost and the protein is instead routed to the
nucleus. Our data suggest that RNase Z
L is the enzyme involved in both, nuclear and mitochondrial tRNA 39 end maturation.
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Introduction
tRNAs are generally synthesized as immature precursors with
extensions on both ends [1]. Removal of these extra sequences is
essential for tRNA function. Extraneous nucleotides at the 59 end
are removed by a single endonucleolytic cleavage catalyzed by an
enzyme known as RNase P [2,3]. 39 end processing is either
accomplished by precise endonucleolytic cleavage too, or by the
concerted action of multiple exo- and endonucleases [1,2,4]. The
enzyme responsible for the first, exclusively endonucleolytic
pathway is called RNase Z (or tRNase Z; EC 3.1.26.11) [2,5–8].
RNase Z enzymes belong to the metallo-b-lactamase superfam-
ily. In addition to the diagnostic a–b/b–ab -lactamase-fold, a
protruding flexible arm involved in binding tRNA precursors is
characteristic for RNase Z structures. There are two forms of
RNase Z, one of 280 to 360 amino acids (RNase Z
S) found in
archaea and many, but not all bacteria and eukarya, and one,
more than twice this length (750–930 amino acids; RNase Z
L),
exclusively found in eukarya. The primary structure of RNase Z
L
suggests that it has evolved from RNase Z
S by duplication. While
all eukarya appear to have at least one RNase Z
L gene, some also
have RNase Z
S, or more than one gene encoding a long and/or
short form of RNase Z.
In the human genome RNase Z
S is encoded by ELAC1 and
RNase Z
L by ELAC2 (the gene names refer to their homology to
the Escherichia coli RNase Z gene elaC). Recombinant proteins
derived from both genes have RNase Z activity, i.e., cleave tRNA
precursors at their 39 end in vitro [9]. The predicted mitochondrial
targeting sequence of ELAC2 suggests that RNase Z
L localizes to
mitochondria, whereas RNase Z
S might accordingly be assumed
to be responsible for the processing of nuclear encoded tRNAs.
However, due to a lack of systematic approaches, the available
experimental evidence is largely inconclusive. RNase Z
S was found
mainly in the cytosol upon biochemical fractionation [10] and
subcellular localization of RNase Z
L (ELAC2) was either reported
to be mostly cytosolic [11], exclusively mitochondrial [12], or
ubiquitous (cytosol, nucleus, and mitochondria) [13].
To clarify the subcellular distribution of the two human RNase
Z isoforms we studied the localization of enhanced green
fluorescent protein (EGFP)-tagged variants in human cell lines.
By bioinformatics and experimental manipulation of the transla-
tion initiation site of RNase Z
L (ELAC2) we moreover revealed the
basic mechanism underlying the observed dual nuclear/mito-
chondrial targeting of RNase Z
L.
Results




Different bioinformatic tools invariably predicted human RNase
Z
L to be targeted to mitochondria by its N-terminal amino acid
sequence. Moreover, amino acids 28 to 35 are predicted to
comprise a nuclear localization signal. In contrast, RNase Z
S
appears to neither contain a mitochondrial targeting sequence nor
a nuclear localization signal.
To address the localization of both proteins experimentally we
expressed their complete coding sequences tagged by EGFP in
human 293 cells. To avoid interfering with putative N-terminal
sorting signals we fused the EGFP-tag to the C-termini of the
proteins. RNase Z
L localized to the nucleus and the mitochondria
of transfected cells, but showed no cytosolic fluorescence
(Figure 1A–C). RNase Z
S on the other hand, was found primarily
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S-EGFP expressing cells
also displayed some weak nuclear fluorescence. In contrast, EGFP
alone distributed evenly throughout the cytosol and the nucleus
(data not shown).
Dual nuclear/mitochondrial targeting of RNase Z
L by
alternative translation initiation
How does the nuclear fraction of RNase Z
L escape the
mitochondrial import pathway? The assigned start codon of
human RNase Z
L (ELAC2) appears to be in a suboptimal
configuration for efficient initiation of translation (Figure 2).
Initiation sites in mammalian mRNAs usually conform at least in
part to the sequence GCCRCCAUGG [14]. The strongest
determinants for translation initiation besides the AUG itself are
a purine (R), preferably an A, at 23 and, especially in the absence
of A
23, a G in position +4. The first AUG of human RNase Z
L
mRNA lacks both, A
23 and G
+4. The next AUG, 45 nucleotides
downstream, is preceded by ACC and thus in a much more
favorable context for translation initiation. However, proteins
translated from this second putative initiation site would lack 15 N-
terminal amino acids and thereby most of the predicted
mitochondrial targeting sequence. In fact, unlike full length
RNase Z
L (826 amino acids), the slightly shortened RNase Z
L
(811 amino acids) is no longer predicted to localize to
mitochondria by any of the employed bioinformatic tools, whereas
the predicted nuclear localization signal is not affected. The
peculiar configuration of the two putative start codons is conserved
among mammalian ELAC2 homologs (Figure 2). While position
23 is never occupied by a purine in the case of the first AUG, the
second AUG is always preceded by a purine at 23. Also other, less
important determinants for efficient translation initiation (C
24 and
C
22) conform more closely to the consensus sequence in the case
of the second putative initiation site. The second AUG thus
invariably appears to be in a better initiation context than the first.
To test whether the observed dual nuclear/mitochondrial
localization of human RNase Z
L is indeed due to alternative
translation initiation we prepared two variants of the ELAC2
cDNA and analyzed their subcellular localization. On the one
hand, we changed the sequence preceding the first AUG to the
more favorable initiation context GTCACC, on the other hand,
we deleted the first 15 amino acids to allow translation from the
second AUG only. Modification of the nucleotides preceding the
first AUG to conform to the consensus gave rise to an RNase Z
L
exclusively localized to mitochondria (Figure 3A–C). Others also
recently reported a mitochondria-restricted localization of RNase
Z
L; notably, their epitope-tagged RNase Z
L was expressed from an
(unintentionally) initiation context-optimized cDNA too [12]. As
further predicted by our model, a cDNA devoid of the first few
codons resulted in an RNase Z
L variant exclusively found in the
nucleus (Figure 3D; with the expected exception of cells
undergoing mitosis).
In contrast to previous reports [11,13] we did not observe any
appreciable cytosolic RNase Z
L in any of our experiments with
Figure 1. Subcellular localization of EGFP-tagged RNase Z
L and RNase Z
S in 293 cells. (A) RNase Z
L-EGFP; (B) immunofluorescence
localization of subunit I of cytochrome c oxidase (mitochondrial staining) in the cells shown in (A); (C) overlay of (A) and (B) with nuclei shown as inset;
(D) RNase Z
S-EGFP with nuclei shown as inset. Confocal laser scanning microscopy (scale bar, 10 mm); insets showing nuclei by epifluorescent
microscopy.
doi:10.1371/journal.pone.0019152.g001
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nuclear RNase Z
L was also completely re-imported after re-
formation of the nuclear membrane. The localization pattern of
RNase Z
S,R N a s eZ
L, and the two RNase Z
L translation
initiation variants was identical in 143B osteosarcoma cells
(Figure S1).
Discussion
Determining an enzyme’s subcellular localization is crucial to
fully comprehend its biology. Eukaryal cells generally transcribe
and process tRNA precursors in the nucleus and mitochondria
(plants moreover in chloroplasts). All eukarya also have one RNase
Z
L gene, and it appears evolutionary optional to have further
RNase Z genes encoding either short or additional long forms.
Consistently, RNase Z
L is targeted to the nuclear and the
mitochondrial compartment in organisms where it is the only
form of RNase Z, like Saccharomyces cerevisiae or Drosophila
melanogaster [15,16]. Yet, despite the additional presence of an
RNase Z
S, we show that human RNase Z
L localizes to nuclei and
mitochondria too, while RNase Z
S is found mainly in the cytosol.
Only if there is more than one RNase Z
L gene, the general dual
nuclear/mitochondrial localization of RNase Z
L appears dispens-
able. In Arabidopsis thaliana one of the two RNases Z
L is still dual
targeted while the other one is found in mitochondria only [17]. In
the yeast Schizosaccharomyces pombe finally, the two RNases Z
L are
confined to the nucleus and the mitochondria, respectively [18].
Interestingly, also in plants, where there are up to four RNases Z,
only the long forms localize to nuclei and/or mitochondria,
whereas the two RNases Z
S are found in the cytosol and in
chloroplasts, respectively [17].
The cytosolic localization of human RNase Z
S indicates that it is
not involved in the processing of tRNA primary transcripts. This
conclusion is consistent with its low tRNA processing efficiency in
vitro [19] and with the fact that its gene (ELAC1) is part of a
homozygous deletion in a lung cancer cell line, and thus
apparently dispensable for cell survival and growth [20].
Unfortunately, there are currently no more clues to the biological
role of human RNase Z
S.
In contrast, the subcellular localization of human RNase Z
L
suggests a role in the 39 end maturation of nuclear and
mitochondrial encoded tRNAs. Such a dual role has in fact been
demonstrated for D. melanogaster RNase Z
L [16]. It is unclear
however, whether RNase Z
L is generally the only nuclease
responsible for tRNA 39 end formation. While there is evidence for
alternative, exonucleolytic pathways for nuclear tRNA maturation
in different eukarya [1], the polycistronic nature of mitochondrial
tRNA precursors appears to strictly require an endonuclease [21].
Notably, only mitochondrial and chloroplast RNases Z are
essential in A. thaliana [17]. However, because both RNases Z
L
are targeted to mitochondria, only the double mutant is lethal in
this case [17].
Figure 2. Alignment of the two putative initiation sites of mammalian RNase Z
L mRNAs (ELAC2 homologs). Optimal (consensus)
translation initiation context of mammalian mRNAs [14] shown on top. R
23, AUG
Start, and G
+4 outlined; shading indicates identity to more than 50%
of the sequences.
doi:10.1371/journal.pone.0019152.g002
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drial localization of human RNase Z
L appears to be the alternative
use of two translation initiation sites. The first AUG of mammalian
RNase Z
L is in a poor context for initiation and thus apparently
passed by most scanning ribosomes, while the second AUG more
closely conforms to a consensus initiation site and appears to be
used preferentially. This mechanism of alternative translation
initiation has been described as context-dependent leaky scanning
[14]. In the case of mammalian RNase Z
L downstream initiation
results in the loss of most of the mitochondrial targeting signal,
whereby the protein translated from the second AUG is no longer
imported into the mitochondrial matrix, but routed to the nucleus
via its nuclear localization signal. Accordingly, experimental
optimization of the context of the first AUG resulted in an RNase
Z
L exclusively targeted to mitochondria, whereas its elimination
produced nuclear RNase Z
L only. This moreover implies that the
mitochondrial targeting signal is either dominant over the nuclear
localization signal, or the latter masked by the presence of the
former [22]. A similar localization mechanism has been proposed
for two other human nuclear/mitochondrial proteins, DNA ligase
III and DNA topoisomerase IIIa [23,24].
Context-dependent leaky scanning does not exclude that there
are other, currently unknown mechanisms involved in regulating
the balance between nuclear and mitochondrial RNase Z
L.W e
previously reported a reduction in mitochondrial RNase Z activity
in human cells lacking mitochondrial DNA (r
0 cells) [25]. More
recently, it was reported that the RNase Z
L coding ELAC2 mRNA
is in fact down-regulated in r
0 cells [12]. It is not known whether
this down-regulation is accompanied by the preferential targeting
of the remaining RNase Z
L to the nucleus or affects the cellular
RNase Z
L pool as a whole and thereby possibly contributes to the
slower growth of r
0 cells.
We did not observe any RNase Z
L in the cytosol. Previously,
others had reported a predominantly cytosolic localization of
ELAC2 upon biochemical fractionation [11] and a ubiquitous
cellular localization of RNase Z
L by immunofluorescence [13].
Experimental design and methodological approach appear to
account for these discrepancies. A protein tagged at its N-
terminus by two FLAG epitopes was expressed from an
optimized initiation site in the first study [11]. Thereby the N-
terminal mitochondrial targeting signal was displaced and
initiation from the downstream AUG, responsible for translation
of nuclear RNase Z
L, prevented. The N-terminal tag might have
additionally masked the nuclear localization signal [22]. Some
nuclear proteins moreover have a strong tendency to leak to the
cytosol upon biochemical fractionation. Concerning the latter
study [13], the uniform immunofluorescence throughout the cell
casts doubts on the specificity of the antibody used. In the end, it
is unlikely that the EGFP attached to the C-terminus of RNase
Z
L in our study prevented its cytosolic localization, as this was
neither the case with EGFP alone nor with EGFP tagged RNase
Z
S.
Figure 3. Subcellular localization of EGFP-tagged RNase Z
L variants with modified translation initiation sites in 293 cells. (A) RNase
Z
L-EGFP variant with an optimized translation initiation context of the first AUG; (B) immunofluorescence localization of subunit I of cytochrome c
oxidase (mitochondrial staining) in the cells shown in (A); (C) overlay of (A) and (B) with nuclei shown as inset; (D) RNase Z
L-EGFP variant without the
first 15 amino acids, nuclei shown as inset. Confocal laser scanning microscopy (scale bar, 10 mm); insets showing nuclei by epifluorescent
microscopy.
doi:10.1371/journal.pone.0019152.g003
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Animal cells use two radically different enzymes for the
processing of tRNA 59 ends in the nucleus and mitochondria
[26–28]. In contrast, key enzymatic components appear to be
shared for the formation of tRNA 39 ends. RNase Z
L is localized to
both compartments of tRNA biogenesis, and considering that only
a single gene (TRNT1) for ATP(CTP):tRNA nucleotidyltransfer-
ase, the CCA-adding enzyme has been identified in the human
genome, it appears reasonable to assume it is shared as well [29].
An analysis of TRNT1’s N-terminus and putative translation
initiation sites at least suggests that it employs the same basic





For the prediction of subcellular localization we used the
following tools: LOCtree [30], TargetP [31], MitoProt II [32],
Predotar [33], and PredictNLS [34].
Mammalian RNase Z
L gene sequences were retrieved from
Ensembl [35]. Sequence alignments were generated with Mac-
Vector 6.5 (Oxford Molecular).
cDNA expression plasmids
The coding sequences of ELAC1 (NM_018696) and ELAC2
(NM_018127) including 15 nucleotides of 59 untranslated region
preceding the start codon were PCR amplified from HeLa cell
(ATCC# CCL-2) cDNA using primers containing BamHI and in-
frame XbaI restriction sites. PCR products were cloned into a
pcDNA4/TO (Invitrogen) that was modified by insertion of the
EGFP coding sequence from pEGFP-N3 (Invitrogen) into its ApaI
site. Proteins expressed from these plasmids are composed of their
complete native amino acid sequence fused at their C-terminus via
a short linker peptide (SerArgGlyProAlaThr) to EGFP.
The native ELAC2 expression plasmid was modified by site-
directed mutagenesis using the QuikChange (Stratagene) protocol:
GTCACC replaced (i) the natural 59 untranslated region, or (ii) the
59 untranslated region plus the first 45 nucleotides of coding
sequence.
Cell lines, staining, and microscopy
Stable T-REx-293 (Invitrogen) cell lines were generated as
described recently [28]. For each expression cassette we isolated
and analyzed several clones.
Cells were grown on cover slips and expression induced with
tetracycline at 0.2 mg/ml. Paraformaldehyde fixed cells were
stained with bisbenzimid H33342 and embedded in Kaiser’s
glycerol gelatin. For mitochondrial staining cells were fixed,
permeabilized with 0.1% Triton X-100, and incubated with a
monoclonal antibody specific for subunit I of cytochrome c oxidase
(Molecular Probes A6403) at 5 ng/ml. For detection biotinylated
anti mouse IgG and Texas Red conjugated streptavidin were used.
A conventional epifluorescent and a dual-channel confocal laser
scanning microscope (Olympus FluoView) were used. Pictures
were processed with the FluoView application software (Olympus).
A 143B (ATCC# CRL-8303) derived cell line stably expressing
DsRed2 (Clontech) targeted to mitochondria by the signal peptide
of cytochrome c oxidase subunit VIII was selected. This cell line
was transfected with the ELAC expression plasmids by a magnet
assisted transfection procedure according to the instructions of the
supplier (IBA BioTAGnology).
Supporting Information
Figure S1 Subcellular localization of EGFP-tagged RN-
ase Z
S, RNase Z
L, and RNase Z
L variants with modified
translation initiation sites in 143B cells. (A) RNase Z
S-
EGFP; (B) RNase Z
L-EGFP with native translation initiation
context; (C) RNase Z
L-EGFP variant with an optimized
translation initiation context of the first AUG; (D) RNase Z
L-
EGFP variant without the first 15 amino acids; (E–H) DsRed2
labeled mitochondria of cells shown in the same row; (I–L) nuclear
staining of cells shown in the same row.
(TIF)
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